Skip to content

Reducing Delay in Vaccination of Children: Logistic Barriers

The REDIVAC Study-Reducing Delay in Vaccination of Children Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03516682
Acronym
REDIVAC-LB
Enrollment
250
Registered
2018-05-04
Start date
2018-06-01
Completion date
2019-03-31
Last updated
2019-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Communicable Disease

Keywords

Logistic Barriers to Vaccination

Brief summary

This study will assess the impact of automated reminders for the 6 month and 12 month vaccine visits to increase vaccination in parents experiencing logistic barriers to vaccination.

Detailed description

Parents of children less than 11 months of age will be identified as delayed or missing vaccinations due to logistic barriers in the Kaiser Permanente Colorado population. Parents identified will be randomized to the intervention arm or the usual care arm. Those in the intervention arm will receive automated reminders for the 6 month and 12 month vaccine visits. Reminders will include scheduling information as well as access to a website with vaccine and scheduling information. They will also have an opportunity to provide preferences in how they receive the automated reminders (text, phone or email). There will be 2 reminders before the 6 and 12 month visits and 2 after the 6 and 12 month visits. Parents will be excluded from receiving reminders if they have received vaccines within the time frame when they are eligible to receive another vaccine or have a well child visit scheduled.

Interventions

BEHAVIORALReminders

Automated reminders for the 6 month and 12 month vaccine visits for parents experiencing logistic barriers to vaccination.

Sponsors

University of Colorado, Denver
CollaboratorOTHER
Kaiser Permanente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The Investigator and Analyst will stay blinded to the randomization arm throughout the trial.

Eligibility

Sex/Gender
ALL
Age
1 Months to 11 Months
Healthy volunteers
No

Inclusion criteria

* Parents of children less than 11 months of age * Currently enrolled at Kaiser Permanente Colorado at the time of identification * The child is missing recommended vaccinations

Exclusion criteria

* Non-english speaking * diagnosis code indicating parent vaccine refusal

Design outcomes

Primary

MeasureTime frameDescription
Vaccines received (Electronic Health Record)up to a year of follow upVaccination records from the participants electronic health record will be used to measure vaccines received. Vaccines received is a dichotomous variable indicating if any vaccines were received while enrolled in the study

Secondary

MeasureTime frameDescription
Vaccine dose (Electronic Health Record)up to a year of follow upVaccination records from the participants electronic health record will be used to measure vaccine dose. Vaccine dose is a measure of the vaccine doses that the child could have received while enrolled in the study, the number of vaccine doses received

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026